About 5 results found for searched term "DL-Homocysteine" (0.12 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M14342 | DL-Homocysteine | Metabolite/Endogenous Metabolite |
| DL-Homocysteine is a weak neurotoxin, and can affect the production of kynurenic acid in the brain. Homocysteine is a sulfhydryl-containing amino acid, synthesized from methionine. It is a non-essential, non-proteinogenic amino acid. It is an important determinant of the methylation cycle and is present in the plasma in four forms. | ||
| M51312 | N-Butyryl-DL-homocysteine thiolactone | Others |
| N-Butyryl-DL-homocysteine thiolactone is an N-acyl homoserine lactone (AHL) analogue. | ||
| M55431 | DL-Homocysteine-d4 | Metabolite/Endogenous Metabolite |
| DL-Homocysteine-d4 | ||
| M11510 | DL-Propargylglycine | Others |
| PAG | ||
| Dl-proparyngine (PAG) is an irreversible inhibitor of cysteine γ -lyase (GCL), a key enzyme involved in glutathione synthesis, regulation of homocysteine concentration and metabolism to sulfur pathway that mediates cysteine synthesis. | ||
| M39109 | DL-Homocystine | Metabolite/Endogenous Metabolite |
| DL-Homocystine is the double-bonded form of homocysteine and homocysteine is recognized as an important substance in the pathogenesis and pathophysiology of schizophrenia. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
